对复合生物相同激素治疗的伦理评估
R P Kauffman1, E J MacLaughlin2, L A Courtney2
1Department of Obstetrics and Gynecology, TX Tech University Health Sciences Center School of Medicine, Amarillo, TX, USA.
复合生物相同激素疗法 (cBHT) 越来越受欢迎,但缺乏科学支持,并引发了安全问题. 由于伦理和实际原因,医疗保健提供者应该阻止其作为一线治疗的使用.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 医学伦理 医学伦理
背景情况:
- 复合生物相同激素疗法 (cBHT) 正在获得越来越多的普及.
- 许多FDA批准的激素产品以各种配方和剂量提供.
- 支持cBHT的说法通常缺乏强有力的科学证据.
研究的目的:
- 评估对cBHT.提出的声明的科学有效性.
- 解决关于cBHT的纯度,有效性,生物可用性和安全性的担忧.
- 检查在医疗和药房实践中促进cBHT的伦理含义.
主要方法:
- 审查关于cBHT的现有科学文献.
- 对cBHT支持者提出的说法进行分析.
- 对处方实践的伦理分析.
主要成果:
- 许多关于cBHT的说法没有得到精心设计的研究的证据.
- 关于cBHT的纯度,有效性,生物利用性和安全性存在重大担忧.
- 处方cBHT作为一线治疗,为医疗保健专业人员提出了伦理问题.
结论:
- 应该阻止cBHT作为一线治疗的推广和处方.
- 医疗保健专业人员必须优先考虑患者的福利,并遵守道德实践标准.
- 需要进一步的严格研究来验证cBHT的说法.
更多相关视频
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
11:51Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
相关概念视频
Bioequivalence: Overview
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Drug Biotransformation: Overview
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
